Review Article

Pharmacotherapies for Central Post-Stroke Pain: A Systematic Review and Network Meta-Analysis

Table 1

Characteristics of the included trials.

Study IDSample sizeCause of painRCT designInterventionAdministration method of the intervention and treatment durationControlPain scaleAssessment time

[19]16Stroke or spinal cord injuryCross-over, 3-week washoutLidocaine, 5 mg/kg/dayIV; 3 weeks0.9% saline100-VASUntil post-infusion
[20]16Stroke or spinal cord injuryCross-over, 3-week washoutMorphine (9-30 mg/day;  mg per day in average)IV; 3 weeks0.9% saline100-VASUntil post-infusion
[21]20StrokeCross-over, 2-week washoutNaloxone, 8 mg/sessionIV; 2 weeks0.9% saline100-VASUntil post-infusion
[22]42StrokeCross-over, 2-week washoutLevetiracetam, started at 1000 mg and increased every 2 weeks to 3000 mgOral; 8 weeksPlacebo pills10-NRSPost-treatment
[12]58StrokeParallelPrednisolone, 10 mg/day for 2 monthsOral; 4 weeksNo prednisolone100-VASPost-treatment
[23]219StrokeParallelPregabalin, 150-600 mg/dayOral; 12 weeksPlacebo pills10-NRSPost-treatment
[24]39Acute thalamic strokeParallelAmitriptyline, 10-75 mgOral; 52 weeksPlacebo pillsNACensor point within one year
[25]15StrokeCross-over, 1-week washoutAmitriptyline, 12.5-50 mgOral; 4 weeksCarbamazepine (200-800 mg) or placebo pills10-step verbal scalePost-treatment
[13]26Ischemic stroke in MCA territory; ICH stroke in basal gangliaParallelEtanercept, 25 mgPeri-spinal; 2 weeks0.9% saline100-VAS or 10-NRSPost-treatment
Vesterguard et al., 2001 [26]27StrokeCross-over, 2-week washoutLamotrigine, tapered from 25 mg/day to 200 mg/dOral; 8 weeksPlacebo pills10-NRSPost-treatment
Eun Young et al., 2016 [11]21First-ever strokeParallelPamidronate, 60 mg/session, 3 infusions every two days for six daysIV; 2 weeksOral prednisolone 1 mg/kg/day100-VASPost-treatment
[27]33Stroke, spinal cord lesion or other central nervous lesionsParallelKetamine 50-75 mg/session, 5 sessionsSelf-powered disposable patch; one weekPlacebo patch100-VASPost-treatment
[28]40Stroke, spinal cord lesion or other central nervous lesionsParallelPregabalin, 150-600 mg/day, 4 weeksOral; 4 weeksPlacebo pills100-VASPost-treatment